IOBT vs TYL · $98.2M cap vs P/E 89, rev $1.26B
IO Biotech Inc (IOBT) versus Tyler Technologies Inc (TYL) — a side-by-side from cached financials, not a winner call.
IO Biotech Inc (IOBT) is a biotechnology company listed on US.
Tyler Technologies Inc (TYL) is a software - application company listed on US.
IOBT does not have a complete income-statement cache yet.
Latest reported TYL revenue for 2026-06-30 was $1.26B. Net income was $174.7M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
IOBT currently screens at market cap $98.2M. TYL currently screens at market cap $25.57B and trailing P/E 89.3.
Not investment advice. Open the IOBT and TYL stock pages for the full models.
Not investment advice.